Soros buys Arthur J. Gallagher, boosts Accenture in Q4
George Soros’ Soros Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund’s new buys during the fourth ...
FTSE 100 slips back after pound hits almost-two month high
The biggest fallers on the FTSE 100 were Schroders, down 12p to 371.6p, IAG, down 8.9p to 338.5p, AstraZeneca, down 256p to ...
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...
Biogen Q4 Earnings Review: Why I'm Calling Time On This 'Powder Puff' Pharma
Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...
AstraZeneca reports positive results for Imfinzi MIBC regimen
AstraZeneca (NASDAQ:AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of muscle-invasive bladder cancer, or MIBC. The analysis showed that ...
Hedge fund Citadel takes short position in GSK, FT reports
Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, ...